The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4(+) T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway

Vaccination remains the most cost-effective biomedical approach for controlling influenza disease. In times of pandemics, however, these vaccines cannot be produced in sufficient quantities for worldwide use by the current manufacturing capacities and practices. What is needed is the development of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Jain, Sonia, George, Parakkal Jovvian, Deng, Wangyan, Koussa, Joseph, Parkhouse, Kaela, Hensley, Scott E., Jiang, Jiu, Lu, Jie, Liu, Zhuyun, Wei, Junfei, Zhan, Bin, Bottazzi, Maria Elena, Shen, Hao, Lustigman, Sara
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595497/
https://ncbi.nlm.nih.gov/pubmed/29764680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.05.029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados